awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33620083-6CBC3CA9-AF96-41C4-BC70-BC1C6A05A24C
Q33620083-6CBC3CA9-AF96-41C4-BC70-BC1C6A05A24C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33620083-6CBC3CA9-AF96-41C4-BC70-BC1C6A05A24C
Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial.
P2860
Q33620083-6CBC3CA9-AF96-41C4-BC70-BC1C6A05A24C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33620083-6CBC3CA9-AF96-41C4-BC70-BC1C6A05A24C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1120450299826ac3175ed0c5bd06f5a5675096fc
P2860
Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.